Ricoh Arena, Coventry, UK, 29th-31st July, 2010 cussion/Conclusions: Feeding and swallowing difficulties in 22q11DS can be long term, are not always obvious nor simply related to common underlying medical problems. Difficulties include oral motor delay, behavioural feeding difficulties, and aspiration risk requiring modification of oral intake. A unique pattern of supra-oesophageal reflux is confirmed. Reflux may be overlooked as a primary cause of feeding difficulties, presenting as limited intake or food refusal. A cohort of 90 patients with a diagnosis of the 22q11.2 deletion syndrome confirmed by fluorescence in situ hybridization (FISH) chromosomal analysis were enrolled in the study at the Children's Hospital of Philadelphia, Philadelphia, Pa. All of the patients were referred from the Genetics department at the Children's Hospital of Philadelphia. Ocular abnormalities were evaluated prospectively in 90 patients, and all patients were evaluated by ophthalmologists who were familiar with the study. All patients except for one patient received a dilated, cycloplegic examination with
22q11.2 deletion syndrome is caused by heterozygous loss of a genomic segment in this chromosomal region. Most cases are de novo, but parental studies are usually performed to rule out a familial origin, which allows providing an accurate recurrence risk. We report on a female newborn referred for assessment because of a suspected diagnosis of 22q11.2 deletion syndrome. FISH and MLPA assays confirmed a common 3-Mb deletion. Subsequently, both parents, phenotypically normal, were tested and showed normal MLPA results. However, metaphase FISH showed an apparently deleted pattern in the mother. Additional interphase FISH revealed two 22q11.2 signals next to each other. These findings were interpreted as an uncommon, compensated rearrangement of both maternal 22q11.2 regions, resulting in a deletion in one chromosome 22 and a reciprocal duplication in the homologous one.
Two previous daughters of the mother from different partners were studied and found to have inherited the maternal, rearranged chromosome 22 carrying 2 copies of region 22q11.2. This case has relevant implications for the genetic counselling of this woman, as all her offspring will either inherit the deletion or the duplication. Moreover, it reinforces the importance to perform FISH studies in the parents of a child with 22q11.2 deletion, even if their phenotype is normal. E-Mail: lfernandez.hulp @ salud.madrid.org
Analysis of CNVs in 22q11.2 Deletion Syndrome (22q11DS)
B.S. Emanuel, M. Sheridan, E.H. Zackai, D. McDonald-McGinn, R. Gur, T. Shaikh, B. Morrow Division of Human Genetics, The Children's Hospital of Philadelphia and Department of Pediatrics, The University of Pennsylvania SOM, Philadelphia, Pa., USA Introduction: As part of an ongoing study of Genetic Modifiers for 22q11.2 Deletion Syndrome (HL84410) and as a prelude to Brain-Behavior and Genetic Studies of the 22q11DS (MH 87836), we have genotyped a significant number of CHOP patients using genome-wide SNP arrays. Methods: We used the Affymetrix SNP 6.0 platform. The data were analyzed using CNV analysis tools within the Partek Genomics Suite and further analyzed using our 'in-house' software. We focused only on CNVs that were detected by both approaches and concentrated on larger CNVs, represented by more than 50 probes, as they are less likely to be false positives. CNVs are labeled as duplications or deletions (heterozygous or homozygous). Results are compared to the Database of Genomic Variants (DGV) and 'in-house' controls. Results: The 22q11.2 deletion is usually the largest CNV detected at 2,984,973 bp. In almost all of the patients, large CNVs in addition to the 22q11.2 deletion were identified. A total of 962 additional CNVs represented by 1 50 probes were detected by both approaches in the initial 101 patients studied. The majority (85%) were either common CNVs or did not contain genes. Several of these large CNVs were rare and not detected in healthy controls in our 'inhouse' dataset or in other control CNV databases. A few of these findings are notable as they contain genes that have been previously implicated in known genetic disorders. One of the 22q11DS patients also had an ϳ 3-Mb deletion in chromosome 5p14. The 22q11DS patient carrying this additional chromosome 5 CNV is known to have symptoms suggesting a neuropsychiatric phenotype. Another 22q11DS patient was found to carry an ϳ 1.5-Mb deletion at chromosome 16p13.11. Deletions and reciprocal duplications in this region have been associated with SCZ and MR. The detected CNVs have been validated using FISH and/or real-time quantitative PCR. Discussion: Although the current cohort of patients has not been extensively screened for neuropsychiatric disorders, CNVs were detected that affect genes or chromosomal regions that have been implicated in neuropsychiatric disease. These preliminary observations strongly support our hypothesis that there may be other CNVs or alterations within the genomes of 22q11DS patients that predispose to neuropsychiatric and related phenotypes.
E-Mail: beverly @ mail.med.upenn.edu
Introduction: Both structural abnormalities and neuromuscular impairment seem to be factors in the aetiology of velopharyngeal dysfunction (VPD) in patients with 22q11.2 deletion syndrome (22q11DS). Muscular and neurologic problems have been associated with 22q11DS both clinically and genetically. As suggested by the murine model of 22q11DS, primary aberrant myogenesis leads to aberrant neurogenesis. The objective of this study was to confirm a myogenic component in the aetiology of VPD in children with 22q11DS. Methods: In this case-control study at a tertiary children's hospital, specimens of the pharyngeal constrictor muscle (PCM) were taken from 8 children with 22q11DS (5 females, mean age 6.5 years, range 4.1-10.0 years) and 8 children without 22q11DS (4 females, mean age 7.0 years, range 4.3-11.9 years) during velopharyngoplasty. Histologic properties were compared between the groups. Results: Qualitatively, the PCM of children with and without 22q11DS do not differ regarding the presence of increased perimysial and endomysial space, fibre grouping by size or type, or internalized nuclei. Quantitatively, the specimens do not differ regarding the percentage of type I fibres (30.6 vs. 25.7%, p = 0.46, mean difference 4.9%, 95% CI: -7, 17%), or the diameters of type I (19.3 vs. 19 .6 m, p = 0.92, mean difference -0.3 m, 95% CI: -5, 4 m) and type II fibres (24.7 vs. 23.3 m, p = 0.25, mean difference 1.4 m, 95% CI: -2, 5 m). In all children with VPD, the diameters of the type II fibres are more than 12% larger than the type I fibres. Conclusions: Based on the histology of the PCM, relative to non-syndromic counterparts, the aetiology of VPD in children with 22q11DS cannot be attributed to innervation or myogenic disturbances. E-Mail: nespruijt @ gmail.com
Gastrointestinal Inflammation in Children with DiGeorge Syndrome
R. Tomar, A.S. Hassan, F. Kiparissi, A. Forsyth, A. Habel, M.A. Elawad Great Ormond Street Hospital for Children, London, UK Introduction: DiGeorge syndrome is a clinical entity that describes the association of thymic hypoplasia or dysplasia with cardiac abnormalities, parathyroid hypoplasia and cleft palate. The majority of children with DiGeorge syndrome have a hemizygous deletion of chromosome 22q11.2 and a significant number of patients have a variable degree of immune deficiency. Although different systemic abnormalities have been described in association with DiGeorge syndrome such as renal, neurodevelopmental and skeletal, there has been no description of the gastrointestinal (GI) features associated with it. Aim: To describe the gastrointestinal disorders in children with DiGeorge syndrome and to determine whether these features are related to the degree of associated immune deficiency. Patients and Methods: Patients with confirmed diagnosis of DiGeorge syndrome and microdeletion of chromosome 22q11.2 who were referred for gastrointestinal assessment and underwent endoscopic evaluation were studied. The presenting symptoms, the histology, total immunoglobulin, IgG subclasses, total lymphocyte count and T cell subsets were assessed. Results: 12 patients (8 females and 4 males) were identified. The commonest presenting symptoms were failure to thrive and protracted diarrhoea (10/12). Six patients had upper endoscopy, 5 had both upper and lower endoscopy, 11/12 (92%) had identifiable pathology in their biopsies. The changes varied from pan-enteric inflammatory process to isolated gastritis, oesophagitis or enterocolitis. The commonest features were plasma cell and lymphocytic infiltration (9/11), while 1 patient had eosinophilic oesophagitis. Total immunoglobulins were low in 8/11 (73%) with low IgG and IgM needing immunoglobulin supplementation, while signs of immune dysregulation with raised IgG subclasses were seen in 3 patients. 11/12 patients had normal lymphocyte count. T cells were absent in 1 patient and slightly low in 2 patients. Discussion/ Conclusion: This is the first study to describe the GI involvement in DiGeorge syndrome. There seems to be clear association between GI inflammations in patients with DiGeorge syndrome in this cohort. The association of gut inflammation and abnormal humoral response may suggest that this association is more common in patients with significant humoral immune deficiency and may suggest a GI autoimmune process. A larger study to look into this association and its mechanisms is warranted. Clinical evidence suggests that patients with chromosome 22q11.2 deletion syndrome (22q11.DS) have an increased prevalence of atopic and autoimmune disease and this has been without explanation. We hypothesized that secondary consequences of the decrement in T cell production could contribute to the clinical picture. Specifically, we hypothesized that the increase in atopy was due to homeostatic proliferation of T cells leading to a Th2 skew. We performed intracellular cytokine staining to define Th1/Th2 phenotypes in toddlers (early homeostatic proliferation) and adults (post homeostatic proliferation) with this syndrome, and controls. To attempt to understand the predisposition to autoimmunity we performed immunophenotyping analyses to define Th17 cells and B cell subsets. Adult 22q11.DS patients had a higher percentage of IL-4+CD4+ T cells than controls. An increased capacity for atopy would be expected in association with high IL-4 producing T cells. Th17 cells were no different in patients and controls, suggesting that deranged production of Th17 cells does not underlie the predisposition to autoimmunity. However, the adult 22q11.DS patients had significantly lower switched memory B cells. This has been seen in settings where T cell help for B cell development is limited and is seen in a number of immune deficiencies with autoimmune manifestations. These studies demonstrate that the decrement in T cell production has secondary consequences on the immune system, which could mold the patients' clinical picture. Background: Most patients with 22q11.2 deletion syndrome (22q11DS) manifest velopharyngeal dysfunction (VPD). Some children exhibit other speech deficits as well, including motor speech delays and phonological impairments. Further complicating the profile, the majority of patients have severe delay in acquisition of language. Management of VPD can therefore be challenging. The optimal timing for surgical intervention in such patients remains uncertain. Methods: A retrospective chart review of 45 patients with 22q11DS who underwent pharyngoplasty (posterior pharyngeal flap and sphincter pharyngoplasty) was conducted. All surgical repairs were performed by a single plastic surgeon at The Children's Hospital of Philadelphia from 1999-2009. Fourteen patients, who either underwent prior surgical intervention at outside institutions or who did not undergo a postsurgical speech analysis, were excluded from the study, leaving a total study population of 31 patients, aged 4-16 y/o. Each patient underwent pre-surgical and post-surgical speech evaluations using the Pittsburgh Cleft Palate Center Weighted Velopharyngeal Incompetence Screening Protocol. Children were divided into age groups and scores were assessed using Pearson Correlation Regression Analysis and Cohen Standardized Difference Analysis of age at time of surgery compared to speech score improvement. Results: The most significant total speech score improvement was found in the 4-6 year-old population, compared to children aged 7 and older. Regression analysis of the total population presented a significant, linear preference for the younger age group (r = -0.479 and p = 0.009). Within the 4-6-year-old population there was no significant benefit for a specific age within the group (r = -0.262 and p = 0.281). Similar analysis was applied to the sub-tests on the scale, including: nasal emission, resonance, and articulation. Conclusion: Whereas improvement is seen in speech in all age groups studied, surgical management of VPD in children with 22q11DS appears to be most beneficial within the age range of 4-6 years. Within this younger group, there does not appear to be a statistical advantage to surgical intervention at any specific age. Other variables, such as motor speech delays, language emergence, and communication frustration, need to be considered when deciding when to intervene surgically in any individual child. Children with chromosome 22q11.2 deletion syndrome typically suffer from a range of cognitive impairments in the domains of spatial, temporal and numerical information processing. This can make it hard for them to find relevant information in their environment, navigate from location to location, estimate the passage of time and think with numbers and quantities. We have been evaluating the hypothesis that all of these impairments are related to a difficulty in mentally representing and processing spatial and temporal information. In particular, we think that mental representation of this kind of information is reduced in resolution making small differences hard to comprehend much in the way that low resolution, grainy digital camera images do not allow for the examination of small details. This might explain why concepts of space, time and number are hard to learn. I shall present some results from a range of experiments designed to test these ideas. I will also present data indicating the differences in the development of these abilities then suggest how these findings point to possible interventions that we hope to develop in the very near future. E-Mail: tjsimon @ ucdavis.edu
Pathways Affected by Loss of TBX1

P. Scambler
Molecular Medicine Unit, UCL Institute of Child Health, London, UK TBX1 haploinsufficiency is the major contributor to the 22q11 deletion phenotype. Using genome-wide expression analyses we have uncovered various pathways that might be important for the morphogenesis of structures affected in 22q11DS. This presentation will review some developmental processes controlled by Tbx1 and highlight new data with special emphasis on the cardiovascular phenotypes. We now know, from conditional mutagenesis, that biallelic expression of Tbx1 in the surface epithelium of the developing mouse embryo is vital for correct fourth arch artery formation and remodelling. Disruption of this process leads to great vessel defects such as interruption of the aortic arch, a typical abnormality seen in 22q11DS. PAA formation requires condensation and formation of endothelial tubes. Remodelling requires a neural crest contribution. PAA remodelling in particular is subject to modifying genetic and environmental influences. We show that the retinoic acid metabolising enzyme Cyp26b1 is required for remodelling. The expression of this enzyme is reduced in embryos lacking Tbx1 . Moreover in doubly heterozygous mutant mice, remodelling is adversely affected resulting in an increased frequency of pharyngeal derivative malformation. SPD, 22q11DS , and control participants were matched on age, gender, and ethnicity and administered the Achenbach Child Behavior Checklist (CBCL) and the Structured Interview for Prodromal Syndromes (SIPS). As a result, 13 control, SPD, and 22q11DS participants were included in the CBCL analyses and 23 participants per group were included for the SIPS analyses. Results: On the CBCL, the 2 high-risk groups demonstrated parallel patterns of score elevations on all scales except the externalizing factor (including delinquency and aggression), where only the SPD group had higher scores than controls. On all other scales, the 22q11DS group demonstrated scores intermediate to those of the SPD and control groups. On the SIPS, both risk groups showed elevated mean positive, negative, and disorganized prodromal symptoms with respect to the control group, but did not significantly differ from each other. Further, approximately 60% of individuals in both groups met symptom criteria for a prodromal syndrome. Discussion: Results suggest that these 2 high-risk groups are more similar than different, and that the SIPS is a valid measure of prodromal symptoms in 22q11DS. Specific symptom comparisons will be discussed in more detail on the poster. Introduction: 22q11DS is associated with increased risk for schizophrenia during adolescence and adulthood. Prodromal symptoms can appear precociously and are an integral part of the 22q11DS profile. While positive symptoms have been good described in 22q11DS, negative symptoms have never been evaluated systematically during adolescence. However, research studies in schizophrenia suggest that they have a greater impact on daily-life functioning than positive symptoms. In the present study, we investigated the evolution of negative symptoms during adolescence and their impact on functioning. Methods: 40 participants with 22q11DS (m = 14.87, SD = 2.12; 60% of girls) were screened for both positive and negative symptoms using the SIPS. In addition, outcome variables were obtained using the Vineland Adaptive Behaviour Scale and the GAF. Factorial analyses were performed to explore the structure of the SIPS. Transversal and longitudinal analyses were also made to evaluate the phenomenology of negative symptoms as well as their impact on communication, daily-living skills, socialization, and general functioning. Results: Descriptive statistics indicates a high frequency of attenuated negative symptoms in 22q11DS adolescents, difficulties in the expression of emotions and avolition in particular. Factorial analysis on positive and negative symptoms provides a clear 2-factor structure, except for 'disorganized communication' (P5) and 'experience of emotions and self' (N4) that load on both factors. Analysis on negative symptoms suggests that 'ideational richness' loads on a distinct factor. Negative symptoms are significantly associated with the VABS and GAF while positive symptoms are not. Discussion/Conclusions: In the present study, we found evidence for the presence of frequent moderate to severe negative symptoms in 22q11DS adolescents. In addition, this symptomatology appears to be relevant because it has an impact on several aspects of daily-life functioning 3 years after. Cognitive and emotional mechanisms underlying these manifestations still need to be explored, but these results already suggest the usefulness of specific psychological interventions targeting negative symptomatology.
E-Mail: Maude.Schneider @ unige.ch
Genetic and Expression Analysis of Familial 22q11.2 Deletions
S.C. Saitta, T. Busse, D.M. McDonald-McGinn, E.H. Zackai, E.A. Goldmuntz, B.S. Emanuel, R.G. Knowlton, D.A. Driscoll
Division of Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pa., USA Familial deletions occur in ϳ 10% of patients and often show discordant phenotypes among affected members. We studied 72 individuals from 27 families where a parent and one or more children were affected. Deletion sizes were identical in families and the standard LCR-A to D deletion was the most prevalent, suggesting that familial deletions occur by the same mechanism as de novo deletions. We used SNP arrays and identified several large secondary CNVs in our cohort. In addition to their 22q11 deletions, a 3-Mb secondary deletion in 5p14.3 was found in an affected mother with epilepsy and 'emotional disorder' but not in her affected daughter who does not share these features. There are 4 genes in the interval (2 are pseudogenes); PRDM9 is a poorly characterized gene while CDH12 encodes N-cadherin 2, a cell adhesion molecule expressed in neuronal tissues. Both patients share a 6q26 deletion containing an exon from PARK2 and the bidirectional promoter shared with its neighbor, PACRG . These genes are involved in CNS development and PARK2 is associated with autosomal recessive Parkinson's disease. In another affected family, the father demonstrates an ϳ 850-kb amplification in Xp22.2 that is not present in his son. The amplification involves several exons of the MID1 gene whose loss-of-function mutations and deletions are associated with Opitz G/BBB syndrome. The CNV is predicted to disrupt the gene and may affect the patient's phenotype. Our data suggests that CNVs throughout the genome can potentially modify the 22q11 deletion phenotype. We further performed Affymetrix exon arrays on a subset of familial deletion samples and found evidence for distinct expression profiles that may correlate with specific phenotypes in our cohort. Overall, utilization of high-throughput techniques has enormous potential to uncover variation throughout the genome that may help explain discordant phenotypes in families and lead to improved outcome prediction and recurrence risk counseling. Background: There is a growing body of evidence which indicates an unequivocal association between 22q11DS and schizophrenia. Deletion of 22q11 is recognised as the third highest risk for the development of schizophrenia, with only a greater risk conferred by being the child of 2 parents with schizophrenia or the monozygotic co-twin of an affected individual. The challenge for clinicians and researchers is to identify early vulnerability traits, symptoms or disorders which may be associated with or predict a later emerging psychotic disorder, so that at risk individuals may be identified, monitored and treated early to improve outcomes. Identification of these early traits or symptoms firstly requires detailed analysis of the behavioural phenotype in individuals with 22q11DS. The current study aims to define the prevalence and correlates of psychiatric disorders in a population cohort of individuals with 22q11DS in Ireland. The data gained from the study will provide the foundation for future longitudinal studies of risk factors of psychosis in 22q11DS. Methods: Fortyfive individuals with 22q11DS (mean age = 14.6, SD 8.94) and 27 sibling controls (mean age = 12.2, SD 4.12) participated in the study. The rate of psychiatric and behavioural disorders was investigated through a range of semi-structured interviews and standardised questionnaires. This is the first study to use the Comprehensive Assessment of at Risk Mental State (CAARMS), a tool which has been designed to identify a possible prodromal state. Results: Individuals with 22q11DS had high rates of psychiatric disorders and had significant difficulties with social and school functioning (p ! 0.0001) compared to sibling controls. The most frequently occurring were attention deficit hyperactivity disorders (29%, p = 0.001) and anxiety disorders (31%, p = 0.021). Eight individuals (18%) with 22q11DS exhibited subthreshold psychotic symptoms (mean age = 13, SD 2.8, range 7-16 years) and had significantly higher rates of co-morbid psychiatric disorders (p = 0.0003), were found to be more irritable/confrontational with peers/siblings (p = 0.0002), disorganised (p = 0.0001), more likely to be clumsy with coordination difficulties (p ! 0.001) and had peer problems (p = 0.01) compared to individuals with the deletion and without subthreshold psychotic symptoms. No significant association was found between FSIQ and subthreshold psychotic symptoms (p 1 0.05). Conclusion: Children and adolescents with 22q11DS and subthreshold psychotic symptoms were found to be more irritable, disorganised, and clumsy and have peer-related problems. These symptoms may identify individuals who may be at risk for a later emerging psychotic disorder and who may require careful monitoring and follow-up. E-Mail: sprasad @ rcsi.ie
Longitudinal Study of BMI: Is Obesity a Common
Manifestation of this Disorder?
Department of Paediatrics, Timone Children's Hospital, Marseille, France
Aim: To evaluate the pattern of growth in children with a 22q11.2 microdeletion syndrome (22q11DS). Methods: 101 patients with 22q11DS were recruited from 2 genetic departments (Hôpital de la Timone Enfants Marseille, Hopital l'Archet Nice). Patients were examined by a clinical geneticist (N.P. and F.G.). 22q11.2 deletion was confirmed by standard methods. BMI was calculated by Z score of SDS software Calimco. Height, expressed as standard deviation score (SDS), was calculated using French references. Birth weight and length were expressed as SDS for gestational age (Usher Mac Lean Data). Results: Overall mean BMI and height of our cohort were normal (mean BMI: 0.09 8 1.45 SDS, mean height: -0.74 8 1.34 SDS, respectively). Eight patients (8.8%) were suffering from obesity (BMI 1 2 SDS) along their follow-up (4 women, 4 men), overweight developed before age 8 years. 60% of them were born SGA for length, whereas only 28% of nonobese patients were SGA for neonatal length. BMI after 15 years and Z score of BMI after 15 years were predicted by sex, neonatal Usher-McLean weight and height (p ! 0.001). BMI was inversely correlated with neonatal length (Wald 2 ␤ = -1.140) but positively associated with neonatal weight (Wald 2 , ␤ = +2.294). Even though mean measures were above -2 SDS, 22q11DS newborns harboured a significantly short length (-1.44 8 1.25 SDS) in regard to their weight (-0.77 8 0.99 SDS) (p ! 0.01). Finally, patterns of BMI in infancy and childhood differ by gender. BMI of boys dramatically increased from -0.68 8 1.15 SDS to 0.83 8 0.95 SDS during infancy whereas rapid weight gain in girls started from 2 to 4 years (+0.92 SDS) until normal values of BMI. Male gender is significantly associated with a lower postpubertal BMI than female (Wald 2 , ␤ = -1.987). Conclusions: In our cohort, we did not report a higher prevalence of obesity in 22q11DS, but postpubertal BMI is correlated with gender and neonatal length. Speech impairment, including a high prevalence of velopharyngeal impairment (VPI) and disordered articulation, has been reported as a characteristic feature of 22q11 deletion syndrome (22q11DS). So far there is a lack of speech studies that focus on adult populations. The aim of this study was to investigate the prevalence of velopharyngeal impairment, compensatory articulation and reduced intelligibility in adults with 22q11DS. Materials and Methods: A blind assessment of speech in a consecutive series of 24 patients, 16 females and 8 males, with confirmed 22q11DS was performed by 3 experienced speech and language pathologists. The mean age of the patients was 25 years (19-38 years). The perceptual assessment was based on audio tape recordings of a standardized speech material, consisting of repeated sentences and counting. Acoustic analysis with a Nasometer was performed as well as SWINT (Swedish Intelligibility Test). Results: Sixteen patients had a mild to severe VPI. The most prevalent symptoms of VPI were hypernasality and audible nasal airflow. The mean nasalance score was 33% (6-66%). Only 2 patients had disordered articulation, one of these had glottal articulation. A mean of 96% (88-100%) of single words were rated to be intelligible. To reach these results half of the patients had earlier had a velopharyngeal flap. Conclusions: The majority of the patients had normal articulation and good intelligibility while the majority still had persisting problems with velopharyngeal impairment. Children with 22q11 deletion syndrome (22q11DS) are at high risk for intellectual and developmental disabilities, although the nature and severity of these disabilities can vary greatly across children. Frequently within the United States health system, assessment of medical health needs occurs separately from the assessment of cognitive functioning and behavioral health; therefore, the identification of intellectual, developmental, and behavioral disabilities can be delayed, especially for children who are experiencing relatively mild problems. In this study, we used parental report measures to assess the developmental status of 90 infants, children, and adolescents who attended a 22q11DS medical follow-up clinic. Parents completed the Communication and Symbolic Behavior Scales Developmental Profile (CSBS DP) for infants 6 to 24 months, the Child Development Inventory for children 2 to 5 years, and the Adaptive Behavior Assessment System-II for children and adolescents 6 to 21 years of age. A significant majority of the study participants had scores on these question-naires which were indicative of a global developmental delay. Many children also scored poorly on subtests that measured social communication. Implications of these findings are discussed in terms of best-practices for the medical management of children with 22q11DS. We suggest that medical follow-up should include regular developmental and behavioral screenings, that referrals should be provided for the assessment of intellectual, academic, and behavioral functioning, and that clinicians should be aware of the high risk of autism spectrum disorders in children with 22q11DS.
E-Mail: oousley @ emory.edu
Immunological Abnormalities in Adults with 22q11 Deletion Syndrome
A. Hilmarsson, S. Óskarsdóttir, V. Friman
Department of Infectious Diseases, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Introduction: Immunodeficiency of variable severity related to hypoplasia of thymus is one of the characteristic features of the 22q11 deletion syndrome (22q11DS). In children, a low number of T-cells is the most common immunological abnormality. Humoral defects, especially IgA deficiency, have also been reported in both children and adults. So far, studies on immunological features in adults with 22q11DS are scarce and our knowledge on the natural history of the immunodeficiency is limited. The aim of this study was to evaluate immunological abnormalities in adults with 22q11DS and their correlation to infections and autoimmune disorders. Methods: 26 consecutive adult patients (10 males, 16 females, aged 18-44 years, median age 21 years) with 22q11 deletion admitted to the Sahlgrenska University Hospital in Gothenburg were investigated. Data on lymphocyte subsets, lymphocyte proliferative responses, immunoglobulin levels, infections and autoimmune conditions were collected. Results: Six of 26 patients had low immunoglobulin levels, and 4 of these had a clinical picture comparable to common variable immunodeficiency (CVID) (IgG ! 3 g/l, IgA ! 0.07 g/l and normal or decreased levels of IgM). Three patients had low T-cell counts. Four patients had reduced T-cell response to more than one mitogen/antigen, and 12 patients had isolated low response to Candida albicans antigen. Five patients had a history of autoimmune disorders (immunologic thrombocytopenia (ITP) and haemolytic anaemia), and 3 of these had CVID-like disease. 15 patients had frequent or chronic respiratory infection as adults, and the patients with 'CVID' had more severe infections than the rest of the patients. Conclusion: There seems to be a subgroup of individuals with 22q11DS who develop a severe antibody deficiency, and it is important to identify these individuals in order to provide optimal treatment. Autoimmune disorders are common in adults with 22q11 deletion and infections are not only a problem in children but also in a substantial number of adults with 22q11DS. Introduction: Individuals with 22q11.2 deletion (22q11DS) have increased co-morbidity for autism spectrum disorder (ASD). The gender ratio in individuals with ASD who do not have 22q11DS is approximately 4: 1 (M:F). We used 2 screening tools, the Developmental Behaviour Checklist autism screening algorithm (DBC: ASA) and the Social Responsiveness Scale (SRS) to screen for ASD in individuals with 22q11DS who attended a specialist multidisciplinary clinic for young people with 22q11DS. We hypothesized that males with 22q11DS would be more commonly identified with symptoms suggestive of ASD than females. Method: Parents completed the DBC ASA for 46 children (22 M, 24 F, mean age/SD 9.18 8 4) and the SRS for 25 children (10 M, 15 F, mean age/SD 8.32 8 4). Results: DBC ASA : 14 young people (30%) scored at or above cut-off (score 1 17). Similar rates of males and females scored at or above cut-off (6 M, 27% vs. 8 F, 33%). SRS : 9 young people (36%) with 22q11DS scored above cut-off for total difficulties (T score 6 76). Higher percentages of females with 22q11DS than males scored above cut-off for total difficulties (8 F, 53% vs. 1 M, 10%). In addition, higher percentages of females than males scored above cut-off (T score 1 60) on each treatment sub-domain of the SRS: social awareness 86 vs. 50%, social cognition 86 vs. 50%, social communication 86 vs. 60%, social motivation 53 vs. 40%, autistic mannerisms 80 vs. 70%. Conclusion: Results suggest that young people with 22q11DS have high rates of behavioural difficulties that are suggestive of ASD. These difficulties are increased in females with 22q11DS and are in contrast to the pattern of male vulnerability typically reported in neurodevelopmental disorders. Improved psychiatric assessment and management services for males and females with 22q11DS are warranted. Background: 22q11.2 deletion syndrome is common, affecting nearly 1 in 3,000, including many patients with DiGeorge syndrome and 5% of individuals with congenital heart disease. Diagnosis is important because affected patients have impaired immune function and may suffer high mortality rates if given non-irradiated blood products from graft versus host disease. Symptomatic hypocalcaemia may also occur. Our objective was to determine whether mean platelet volume (MPV), available from the routine full blood count, may be a useful and rapid indicator of 22q11.2 deletion. Method: A retrospective case control cohort study analysing MPV and 22q11.2 deletion status was performed in a paediatric population (n = 166) undergoing cardiac surgery between 1999 and 2005. Results: Twenty children were 22q11.2 positive. The median MPV was significantly larger for the 22q11.2-positive patient group compared to the non-22q11.2 patients (10.9 fl vs. 8.6 fl, p ! 0.001). The area under the receiver operating characteristics (ROC) curve of MPV was large enough (0.85) to enable the accurate prediction of 22q11.2 deletion using MPV. Conclusions: MPV is a useful screening test, involving no extra laboratory work, cost or patient discomfort. MPV 1 10 fl is a positive predictor of the presence of 22q11.2 deletion in children with congenital heart disease (specificity 89.7%). This finding should aid rapid decision-making for ordering irradiated blood products to prevent potentially fatal transfusion-associated graft versus host disease. It will alert clinicians to monitor serum calcium levels closely to prevent hypocalcaemic seizures. The 22q11.2 deletion syndrome (22q11DS) is associated with extremely high rates of learning disabilities, attention problems and executive dysfunction. Mathematical disabilities and working memory (WM) deficits are especially common. This may result from dopaminergic alterations caused by haploinsufficiency of the catechol O -methyltransferase (COMT) gene, located within the 22q11 region. Recent research in neuroplasticity indicates that WM skills are malleable, even among the elderly, and can be enhanced through defined active mental exercises. Multiple studies in normal and clinical populations validate computerized WM training for providing substantial and long-lasting gains in WM, attention, and mathematical abilities, in children and adults. Brain imaging studies indicate that intensive structured videogame-like training enhances cortical dopamine D1 receptor density in prefrontal and parietal brain regions critical for WM and math. For this reason, it may be particularly effective for patients with 22q11DS, but this has never been studied. We have neuropsychologically evaluated over 375 patients with 22q11DS. Three unrelated males (ages 5, 11, 20) completed a standardized 25-session computerized WM training program, over 5 weeks. Each session contained 6-8 different exercises, lasting approximately 35 minutes total. Patients used their home computers, and data from each session were automatically uploaded to a central mainframe for off-site monitoring. All 3 patients made steady progress in both visual and auditory WM domains. By the end of training, all 3 showed sizeable improvement in their training scores, compared to their own baselines. Improvements ranged from 42% (age 20), and 79% (age 11), to 104% (age 5). This trend suggests that training at an earlier age of brain development yields greater WM enhancement. These early data indicate that brief structured intensive WM training is well tolerated, and is an effective and convenient intervention for patients with 22q11DS, across a broad age range. Introduction: Individuals with 22q11.2 deletion (22q11DS) are vulnerable to psychiatric co-morbidity. However, in the UK, psychiatric services for people with 22q11DS are limited. We used 2 questionnaires, the Strengths and Difficulties Questionnaire (SDQ) and the Conners' Parent Rating Scale, to compare behaviour between children with 22q11DS and sibling controls. We hypothesized that children with 22q11DS do not differ significantly from siblings on the SDQ and Conners'. Methods: Parents completed the SDQ (95 children with 22q11DS (46 M, 49 F) and 25 siblings (14 M, 11 F)) and the Conners' (88 children with 22q11DS (44 M, 44F) and 25 siblings (13 M, 12 F)). Mean age/SD: 22q11DS = 10 8 4, controls = 11 8 3. Results: Children with 22q11DS typically have significantly higher scores than siblings on both screens (Mann-Whitney U test). SDQ: Total difficulties/ emotional/hyperactivity/peer problems/prosocial p ^ 0.01, conduct disorder p = 0.07. Conners': Inattention/hyperactivity/ ADHD index p ^ 0.01, oppositional p ^ 0.05. More females with 22q11DS than males scored above clinical cut-off: SDQ: Total difficulties 53 vs. 41%, emotional 49 vs. 24%, conduct 31 vs. 26%, hyperactivity 41 vs. 50%, peer problems 51 vs. 48%, prosocial problems 22 vs. 28%. Conners': oppositional 36 vs. 29%, inattention 52 vs. 50%, hyperactivity 36 vs. 23%, ADHD index 57 vs. 41%. Conclusion: Results suggest that young people with 22q11DS have higher rates of behavioural difficulties (ADHD, conduct, emotional, and social) than siblings. These difficulties are increased in females with 22q11DS and are in contrast to the pattern of male vulnerability typically reported in neurodevelopmental disorders. Improved psychiatric assessment and management services for young people with 22q11DS are warranted. In general, the speech outcome after surgery for velopharyngeal dysfunction (VPD) has been reported to be worse in patients with 22q11.2 deletion syndrome (22q11DS) than in patients without the syndrome. Perhaps concomitant pathology in syndromic patients delays normalization of speech. Some patients with 22q11DS fare as well as their non-syndromic counterparts. Prognostic factors are unknown. The objective of this study was to assess the effect of time on functional outcome and search for preoperative prognostic factors for persistent poor speech understandability after velopharyngoplasty in patients with 22q11DS. Methods: A retrospective chart review was done for all patients with 22q11DS and VPD who underwent a primary velopharyngoplasty between 1986 and 2008. Clinically obtained perceptual speech understandability (measured on a scale of 1 to 5, where normal speech is 1) and nasal resonance (percentage scores translated to SDs with normal values between -2.0 and 2.0) were gleaned before and after primary velopharyngoplasty. The potential preoperative prognostic factors gender, age at surgery, lateral pharyngeal wall motion, velar motion, nasal resonance, perceptual speech understandability, presence of a palatal defect, previous intravelar veloplasty, adenoidectomy, hearing loss, and IQ were tested for their value in predicting persistent poor speech understandability measured at least 1 year postoperatively. Results: Data was available for 46 of the 56 patients (82% follow-up), with a mean follow-up time of 7.3 years (range 1.0-19.4 years). Mean postoperative perceptual speech and nasal resonance scores were closer to normal values than mean preoperative scores (2.8 vs. 4.0, and 3.8 vs. 5.6 SD, respectively), and remained stable after longer follow-up. After a minimum of 1 year follow-up, 28% (n = 11/40) of patients were deemed to have persistent poor speech understandability (perceptual speech score of 4 or 5). Of the tested preoperative factors, only the absence of good lateral wall motion predicted persistent poor speech understandability (RR 2.25, 95% CI 1.08-4.67). Conclusions: According to this chart review of patients with 22q11DS and VPD, subjective and objective speech scores improved after velopharyngoplasty, and the results obtained were stable after long-term follow-up. The absence of good lateral wall motion predicted persistent poor speech understandability. E-Mail: mvdmolen.ea @ planet.nl The velocardiofacial syndrome has been reported with a frequency of 1: 3,800 in the Hispanic population. The HIMFG is a reference institution where the patients have always received attention by a multidisciplinary medical group; our clinic was organized in 2009 by participating Audiologist, Cardiology, Geneticist, Endocrinologist and Psychiatrist specialists. The GTG banding and FISH analysis with Tuple 1 probe has been carried out in 105 patients since 2005 when the analysis was available in our hospital. 35 patients were positive for the deletion, 17 analyzed parents were negative. Cytogenetic abnormalities were diagnosed by GTG banding: a male patient with del(10)(p13) and a female patient with t(12; 22). Our data can be compared with those of another National Institute of Health in Mexico City that has newborn patients, the National Institute of Perinatology, where the FISH analysis has been in place since 2000. Other institutions in Mexico City are beginning collaboration for the diagnosis of del22q11.2. The clinical and cytogenetic characteristics of the patients are described in relation to their importance for the treatment and genetic assessment. Historically, patients with the 22q11.2 deletion syndrome were identified using FISH. Later, many were found to have an A-D hemizygous deletion via research probes, including loss of TBX1 positioned between the A-B LCR blocks and considered a major phenotypic contributor based on knockout mice. However, arrays/MLPA now identify atypical/ nested deletions (dels) as well as duplications (dups), including those where TBX1 remains present, raising important management and genetic counseling questions. Methods: To provide such anticipatory guidance, we reviewed our own database and queried 2 large clinical labs comparing frequencies of A-D vs. atypical dels/dups within the DGCR and clinical features. Deletion Results: 438/906 patients within our cohort had deletion sizing by enhanced FISH or array studies. Of these, 65 (15%) had atypical dels including 28 A-B (43%), 10 A-C (15%), 19 B-D (29%), 2 C-D (3%), and 6 'other' (9%) (not flanked by LCR blocks). Thus 21 patients had atypical dels where TBX1 was present. These dels would not have been detectable using standard FISH probes including the 19 B-D's (91%). The reference lab data was similar with 44/231 (19%) and 11/43 (26%) atypical dels found including 38% and 18% B-D's respectively. Findings in our 19 patients with B-D's included: conotruncal cardiac defects (5) (TOF, VSD/coarctation, VSD, IAA, TA); palatal abnormalities (3) (overt cleft, VPI [2]); GERD (3); short stature (3); hypocalcemia (2); iris coloboma; laryngeal web; polymicrogyria; preauricular tags; unilateral renal agenesis; and developmental delay (10). 8/8 patients tested had normal T cells. Of note, 11/19 patients were probands of whom 5/11 (46%) had an affected parent, whereas 7/10 (70%) and 1/1 patients from the reference labs tested were found to be familial. Duplication Results: 15/20 patients with 22q11.2 dups within our cohort were sized. Of these, 14/15 (93%) had standard A-D dups and 1 had an atypical B-D dup. The remaining 5 patients, all from 1 family, were identified by FISH only. Findings in the 14 patients with A-D dups included: cardiac defects (2) (HLHS, PS); GERD (6); seizures (4); macrocephaly; VPI; hypocalcemia; hypothyroidism; preauricular pits; tracheal stenosis; autism/ASD (3); and developmental delay (6). No laboratory confirmed immunodeficiencies were identified. The one patient with an atypical B-D dup had seizures and autism. The reference labs identified 94/130 (72%) and 9/10 (90%) A-D dups including 36% and 0% B-D's respectively. Of our 14 patients with A-D dups, 9 were probands of whom 5 (56%) had an affected parent. From the reference labs, 34/44 (77%) and 2/4 (50%) tested were found to be familial. Conclusion: In combining the net data from our cohort and that of the 2 reference labs we identified a total of 852 patients with copy number abnormalities involving the A-D region of chromosome 22q11.2. Of these 694 were dels and 158 dups. Of these, 271 (0.9%) were found to have a del including 218 with A-D dels (80%). 147 (0.5%) were found to have a dup including 106 (72%) with A-D dups. The most frequent atypical del/dup was B-D with 19/271 (7%) and 13/147 (9%) identified respectively. Thus, 22q11.2 remains a hot spot for copy number abnormalities and with the increasing use of array technology, even patients with mild phenotypes and/or atypical dels/dups are now being commonly identified, of which B-D appears to be the most frequent. In general, structural anomalies may be less common within this sub-cohort, but 29% of our patients with B-D dels had classically associated conotruncal anomalies such as TOF, IAA and TA even with TBX1 present, perhaps suggesting a downstream effect and/ or the involvement of CRKL1 . Moreover, with the exception of the lack of immunodeficiency, the systems involved appear similar to those associated with the standard A-D del. Therefore, while our studies delineate an important new subset of patients, clinical management should likely mirror that which is currently employed for patients with the standard A-D del while management for dups continues to require further discussion. In light of the significantly higher incidence of familial B-D dels compared to family studies using FISH (6%), and dups in general, adult practitioners must be vigilant in their history taking in order to ascertain affected persons with a 50% recurrence risk. Lastly, based on this data, perhaps the term atypical should be revisited. Language difficulties are commonly cited in young children with 22q11.2 deletion syndrome, but the communication skills profile of older children with the condition is less well reported. Although social communication difficulties are known to be a feature, it is not yet clear whether the profile of these is similar to that found in ASD. In recent years there has been increasing interest in the relationship between language and social communication in autism, but the role of emotional understanding has received much less attention. This presentation is part of a larger study which aims to develop this knowledge, examining the emotional understanding and use of language associated with emotion in children with 22q11.2 deletion syndrome aged 11-16 years, compared to typically developing peers and children with ASD, matched on language levels. Methods: Forty young people with 22q11.2 deletion syndrome will be recruited, together with 20 participants with ASD and 20 typically developing children. Participants will be assessed on language and cognitive measures, together with tests of emotional understanding and recognition. The use of emotional language in narrative will be probed using a picture book and conversation. Social communication skills and psychosocial adjustment will be rated using well validated questionnaires. Results/Conclusions: This presentation focuses on the preliminary results from the typically developing group. This data is vital in developing our understanding of the relationship between emotional understanding and communication skills. The extended study will enhance our understanding of the communication skills profile of older children with 22q11.2 deletion syndrome and how these relate to their levels of emotional understanding. E-Mail: anne.mayne @ nhs.net
Clinical and Cytogenetic Analysis by FISH in Patients with Clinical Diagnosis of del22q11.2 Syndrome in Health Institutions in Mexico City
Gastrointestinal Manifestations (GI) of the 22q11.2 Deletion Syndrome
M.R. Mascarenhas, D.M. McDonald-McGinn, E.H. Zackai
The Children's Hospital of Philadelphia, Philadelphia, Pa., USA Introduction: The 22q11.2 deletion syndrome is increasingly recognized in pediatric patients with an incidence of approximately 1 in 3,000. GI manifestations are common and can impact significantly on feeding and growth. To date, there have been few papers on feeding disorders and isolated case reports of various GI anomalies. Methods: A retrospective chart review was conducted on 766 patients with confirmed 22q11.2 deletions followed in the 22q and You Center at CHOP. Data abstracted included GI symptoms, evaluation and management. Results: Average age was 15 years (0.2-62 years). Male:female ratio was 1: 1. Ethnic distribution was predominantly Caucasian (67%), Hispanic (33%) and African-American (10%). 32% of patients had no GI symptoms. In patients with GI symptoms, nasopharyngeal reflux, feeding problems, gastroesophageal reflux and constipation were common. Diagnoses included dysmotility (27), intestinal malrotation (7), esophageal diverticula (5), gastroparesis (5), rectal prolapse (2), esophageal atresia (2), gallstones (2), imperforate anus (1), tracheo-esophageal fistula (1), pyloric stenosis (1), choledochal cyst (1), Hirschsprung's disease (1), and celiac disease (1). About 27% of patients underwent GI testing. Upper GI series and modified barium swallowing study were frequently performed. 5% of patients underwent fundoplication. Feeding tubes were common (27%). Conclusions: Significant GI manifestations are frequent in patients with the 22q11.2 deletion syndrome. Clinicians need to be aware of these conditions to avoid delays in diagnosis. Moreover, all patients with GI symptomatology will benefit from evaluation with a gastroenterologist. E-Mail: mascarenhas @ email.chop.edu
Cardiological Associations of 22q11DS, Their Treatments and Outcomes
B. Marino
University of Rome, 'La Sapienza', Rome, Italy
The characteristic heart defects occurring in children with 22q11 deletion syndrome (22q11DS) are conotruncal defects consisting in anomalies of the outflow tract of the heart. These malformations include tetralogy of Fallot, pulmonary atresia with ventricular septal defect, truncus arteriosus and interrupted aortic arch, but also heart defects not classically considered conotruncal as ventricular septal defect and isolated aortic arch anomalies. Since 1989 we observed about 300 patients with this syndrome. All neonates and children underwent a complete clinical and cardiological assessment and a great number underwent surgical treatment of CHD. We know that in this syndrome, regardless of the type of cardiac defect, some additional cardiovascular anomalies may involve the aortic arch, the pulmonary arteries, the subclavian arteries, the aorto-pulmonary collateral arteries, the infundibular septum and the pulmonary valve. These specific cardiovascular defects deserve attention for the diagnosis and for the cardiac surgery. Some extracardiac problems may complicate the cardiac surgery in patients with 22q11DS. Airway obstructions may be due to vascular ring, laryngeal web or bronchomalacia and bronchospasm. Vasomotor instability may include hypertension or hypotension and bacterial or fungal infections may complicate the post-operative period. In the setting of a congenital cardiac defect the coexistence of a genetic syndrome may add to the complexity of the clinical picture both of the cardiac and extracardiac level. However, based on a large series of cases published in a very recent paper we can see that: considering all types of patients with conotruncal defects, the presence of 22q11DS is not a specific risk factor for surgical mortality and their postoperative long-term survival is comparable with non-syndromic conotruncal defects. In children with 22q11DS, specific cardiac patterns and specific extracardiac anomalies deserve an accurate management and the use of specific protocols of diagnosis and treatment of the cardiac defects. Moreover, the extracardiac problems deserve particular attention and specific treatment, e.g. infection with antibacterial and antifungal prophylaxis, immunology with irradiated blood transfusions, respiratory and metabolic anomalies. The era of predictive medicine can consist in a sort of surgical genomics for the congenital heart defects that can result in a better survival of children with 22q11DS. The clinical features of 22q11.2 deletion are highly variable, even within families in which it is inherited. Here we present the case of a 35-year-old man who was diagnosed after the condition was identified in his nephews and describe the investigation of his immune function. Case: Chromosomal analysis was instigated when the patient's nephews were found to be hemizygous for the 22q11.2 deletion on FISH analysis, in the course of investigations performed for developmental delay. The presence of the same deletion was confirmed by FISH both in our patient, who has a history of an unspecified congenital heart defect, seizures secondary to hypocalcaemia and a psychotic disorder and in his brother, who has a history of a cardiac abnormality. It is assumed that it was transmitted from their father, who had a history of seizures. Following the identification of the 22q11.2 deletion the patient was referred to our department for evaluation of his immune system. There was no history of significant bacterial, viral or fungal infections and no evidence of autoimmunity. He had received all of his childhood vaccinations. Results and Discussion: Immune investigation showed that in common with 20% of patients with 22q11.2 deletions his total numbers of CD4 cells and CD8 cells were normal. However, he had reduced numbers of naïve CD4 and naïve CD8 cells. TREC analysis showed that he had low thymic output. His T cell proliferative response to mitogens and recall antigens was normal and he showed an appropriate humoral response to vaccination. These observations are in keeping with previously reported data. Background: Reality monitoring represents the cognitive processes involved in the discrimination of internally and externally generated information. Studies have described specific patterns of brain activity in the anterior prefrontal cortex when monitoring mental events in perceived or imagined conditions (context) , and when monitoring mental events generated by the participant or by the experimenter (origin) . Such findings motivate investigation of reality monitoring processes in individuals affected by 22q11DS, being a population at high risk of cognitive deterioration. Method: A group of 18 adolescents, affected by 22q11DS and a group of 18 age-matched control subjects underwent an fMRI task examining reality processes. The paradigm was developed to assess abilities to retrieve word association under 2 main conditions: (A) words had been perceived or imagined (context monitoring) , (B) words had been performed by the participant or by the experimenter (origin monitoring) . Images were processed and contrasts analyzed with spm5. Results: Analyses show faulty activity of the anterior prefrontal cortex in adolescents affected by 22q11DS compared to the control group during the 2-task condition. Both groups showed similar activity around the right tempo-parietal junction and left motor cortex when retrieving origin information. Activity was also similar around the bilateral precuneus during retrieval of context information. Conclusion: Adolescents affected by 22q11DS show absence of activity in the anterior prefrontal cortex when undertaking realitymonitoring tasks in comparison to the control group. Results are discussed in relation to functional organization of reality monitoring processes. The 22q11.2 deletion syndrome is a chromosomal deletion disorder associated with a macrothrombocytopenia. Most patients (89%) have a deletion that results in obligate hemizygosity for the important platelet protein, GPIb ␤ . This protein is an integral component of the GPIb/V/IX (CD42) complex on the surface of platelets and has a critical role in hemostasis. We characterized the bleeding manifestations and the level of expression of the CD42 complex in patients with the 22q11.2 deletion to determine if CD42 levels could be used to assess bleeding risk. We evaluated 19 patients with 22q11.2 deletion and compared them to agematched controls. Comparisons were also made in mean platelet volume and platelet count. Expression of the CD42 complex varied in individuals with the 22q11.2 deletion. Only ϳ 25% of patients exhibited significantly decreased CD42 expression. These data suggested a bimodal distribution of CD42 expression. There was a trend toward an inverse relationship between platelet volume and CD42 expression but it did not reach statistical significance. There was an inverse relationship of CD42 levels with platelet count. Fourteen patients had no bleeding; 4 had mild bleeding. One patient had an intracranial hemorrhage, but had a complicated clinical course. Three of the 4 patients with the lowest CD42 levels had at least mild bleeding. In conclusion, we have found that most patients with the 22q11.2 deletion syndrome have normal CD42 levels. Thus, this assay is insensitive for determining GPIb ␤ deletion status and there must be factors other than GPIb ␤ deletion status, which influence CD42 levels. Additional studies are needed to define the bleeding risk in the subgroup with low CD42 levels. 22q11.2 deletion syndrome (22q11DS) poses one of the highest known risks for development of schizophrenia (SZ) in late adolescence or early adulthood. A relatively consistent neuroanatomic phenotype is associated with SZ in the non-22q11DS population, suggesting that an investigation of neuroanatomic changes over time in youth with 22q11DS may identify biological-ly-based markers for SZ in individuals with this genetic disorder as well. Methods: 70 youth with 22q11DS, 27 unaffected siblings of youth with 22q11DS, and 25 community controls were followed at 2 time points (mean time interval, 3.2 years) from childhood (mean age 11.8 years) into mid-adolescence (mean age 15.0 years). Assessments at both time points included anatomic magnetic resonance imaging (MRI) brain scans; IQ and neuropsychological assessments; structured psychiatric interviews (K-SADS-PL); and dimensional measures of parent (Behavior Assessment Scale for Children) and clinician ratings (Scale of Prodromal Symptoms [SOPS]) of child psychiatric functioning. Neuroanatomic regions of interest that have been implicated in schizophrenia and 22q11DS were measured. For the present report, group differences in magnitude of both verbal IQ and neuroanatomic changes over time were assessed with repeated measures ANOVA's. Time (T)1 to T2 change scores were also calculated, and regressed on both positive and total symptom scores for the SOPS. Results: Volumes of the orbitolateral prefrontal cortex (PFC) increased significantly over time for controls, but not for patients with 22q11DS or their siblings. In contrast, all 3 study groups demonstrated longitudinal volumetric increases in cortical white matter, hippocampus, superior temporal gyrus (STG) white matter, and cerebellum, and decreases in dorsal/orbital medial PFC and STG gray matter. Group changes were not observed in cortical gray matter, temporal lobe gray matter, dorsolateral PFC, amygdala volumes, or verbal IQ scores. In patients with 22q11DS, age-related reductions in prefrontal, cortical gray and mesial temporal lobe, STG and cerebellar volumes were all predictive of an increase in total prodromal symptoms at T2. However, only decreases in temporal lobe gray matter (z = -3.13; p = 0.002) and verbal IQ scores (z = -3.04; p = 0.002) predicted to T2-positive (e.g. hallucinations; delusions) prodromal symptoms specifically. Discussion/Conclusions: With the exception of the orbitofrontal PFC, neuroanatomic trajectories in this sample of 22q11DS patients were comparable to unaffected siblings and community controls during the developmental window that spanned late childhood to mid-adolescence. Nonetheless, when the developmental trajectories of several prefrontal, temporal and cerebellar regions went awry, increased symptoms of psychiatric impairment were noted. Interestingly however, only decreases in temporal lobe gray matter volumes and in verbal IQ scores (supporting previous studies of youth with 22q11.2) predicted to positive prodromal symptoms of psychosis. Participants are currently returning for a third visit, at which time they will have reached the age at which they are at the highest risk for the onset of SZ, potentially permitting us to identify specific neuroanatomical trajectories that lead to SZ per se. Asymmetric crying facies (ACF) is a minor congenital anomaly characterized by asymmetry of lower lip depression during crying or grimacing. This is thought to be due to absence or hypoplasia of the depressor anguli oris muscle and has a reported incidence of 0.6% in the general population. ACF can occur in isolation or with major congenital anomalies, most commonly cardiovascular. Reports of deletions in individuals with ACF have ranged from 2-33%, although most series are small. The purpose of this study was to determine the incidence of ACF in a large population of patients with a 22q11.2 deletion and to assess whether the diagnosis of ACF in a newborn should prompt screening for other congenital malformations. Methods: A retrospective medical record review of patients with a confirmed 22q11.2 deletion followed at the '22q and You' Center at CHOP was undertaken. Presence or absence of ACF, sex, race, mode of delivery, perinatal complications, palatal anomalies/velopharyngeal incompetence (VPI), congenital heart disease (CHD), and presence of other congenital anomalies was recorded. Results: 836 records were reviewed. Of these, 117 (14%) were noted to have ACF on physical examination. Within this latter group, palatal anomalies/VPI were common (77%) as was CHD (78%); however, these numbers did not differ significantly from the reported incidence of these abnormalities in our overall population of patients with the 22q11.2 deletion syndrome. Discussion/Conclusions: In this large retrospective review, we report a 14% incidence of ACF in patients with a 22q11.2 deletion, significantly higher than in the general population. We suggest, therefore, that newborns noted to have this subtle facial sign as well as CHD and/or palatal abnormalities be referred for 22q11.2 deletion screening. Conversely, we recommend evaluation for structural anomalies such as CHD in patients with ACF. Whereas the recommendation to screen all patients with ACF for the 22q11.2 deletion remains to be investigated further. 22q11.2 deletion syndrome (22q11DS) is associated with borderline-mild intellectual disability and specific neurocognitive deficits, particularly in prefrontally-mediated executive functions (EF). There is evidence for white matter abnormalities in frontal cortical regions in 22q11DS, however little is known about the development of EF across the age range. Forty-eight individuals with 22q11DS were divided into 3 age groups: Child (7 male; n = 16; 6-11 years; M (SD) age = 8.4 (1.7); mean FSIQ = 72.9); Adolescent (7 male; n = 15; 12-15 years; M (SD) age = 13.1 (0.8); mean FSIQ = 68.0) and Adult (7 male; n = 17; 16-45 years; M (SD) age = 28.8 (11.5); mean FSIQ = 69.6). Forty healthy controls were also recruited and divided into the same 3 age groups: Child (6 male; 6-11 years, n = 12; M (SD) age = 9.3 (1.7); mean FSIQ = 99.1); Adolescent (6 male; 12-15 years; n = 12; M (SD) age = 13.2 (1.1); mean FSIQ = 100.9) and Adult (6 male; 16-45 years; n = 16; M (SD) age = 28.8 (9.4); mean FSIQ = 109). All participants completed standardised tests of a range of executive functions, specifically working memory, planning, problem-solving, strategy formation, cognitive flexibility and inhibition, and cross-sectional developmental trajectories of each function were constructed. No age-mediated improvements on EF tasks were observed in the 22q11DS groups, with the exception of verbal working memory. The control group exhibited significant age-mediated improvements in working memory, strategy formation and planning efficiency. These findings support the hypothesis that 22q11DS individuals experience atypical development of neuroanatomical regions and networks associated with EF in typical individuals. Future longitudinal work is required to examine intra-individual development of executive and non-executive cognitive processes. Making the diagnosis of 22q11 deletion syndrome (22q11DS) is highly dependent on physicians' awareness of this syndrome and its variety of clinical features as well as the severity to which patients are affected. Approximately 75% of patients with 22q11DS have congenital heart disease which often prompts testing. However, for the remaining 25% of patients, the diagnosis is not as easily made and is often delayed. The creation of screening guidelines can aid general pediatricians in not only determining which patients merit screening, but also increase awareness of the wide range of features one can expect to see in affected patients. Based on a retrospective case review of 208 patients seen by general pediatricians as part of the '22q and You' Center, we suggest a set of major and minor criteria, the presence of which should prompt general pediatricians to consider the diagnosis of 22q11 deletion and pursue FISH testing for this deletion. The major criteria include: (1) Congenital heart disease, (2) palatal abnormalities, (3) abnormal immune system, (4) gastrointestinal problems, (5) developmental delay, (6) hypoparathyroidism, (7) cranio-facial abnormalities. There are several minor criteria, some of which include short stature, asymmetric crying facies, and reactive airway disease in addition to several others. FISH testing is recommended in patients with congenital heart disease plus any one major criterion and/or 2 minor criteria, patients with 3 major criteria without heart disease, or patients with 2 major and 2 or more minor criteria. Using these criteria, affected patients who might otherwise not be tested can be accurately diagnosed, appropriately referred to relevant specialists, and receive medical services directed toward their individual needs. Hemizygosity of human chromosome 22q11.2 is associated with prepulse inhibition (PPI) deficits and cognitive impairments. Approximately 90% of 22q11.2 deletion cases show a 3-Mb hemizygosity; the remaining ϳ 10% exhibit nested 1.5-Mb hemizygosity. Because the commonly deleted 1.5-Mb region contains more than 30 genes, it is not possible to determine the precise manner by which individual 22q11.2 genes affect diverse behavioral phenotypes in persons with 22q11.2 hemizygosity. We and others previously identified an ϳ 200-kb human 22q11.2 segment, whose gene dose alteration results in antipsychotic-responsive behavioral sensitization and PPI deficits in mice. The T-box transcription factor Tbx1 , a gene encoded in the ϳ 200-kb region of A.M. Ghanem, O. Gilleard, D. Sell, M. Birch, B.C. Sommerlad North Thames Cleft Service, Great Ormond Street Hospital for Children NHS Trust, London, UK Introduction: Submucous cleft palate (SMCP) is a major abnormality of patients with velocardiofacial syndrome. Treatment of hypernasality resulting from SMCP in these patients is challenging. Our unit's philosophy of treatment of SMCP is to undertake a 2-stage approach. The first-line procedure is an anatomical muscle dissection repair of the palate. The secondary procedure (often a modified Hyne's pharyngoplasty) is planned should there be residual hypernasality after a full assessment of the speech and velopharyngeal characteristics 6 months following the palate repair. The aim of this study is to evaluate the role of velar surgery in the management of SMCP in patients with VCFS. Methods: A retrospective review of all patients treated by a single surgeon using one management protocol over a 10-year period (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) . All speech records were randomized, externally and blindly analysed using the CAPS-A protocol. Results: 57 patients were included with 48 having rateable speech records. Anatomical muscle dissection palate repair significantly improved hypernasality. There was no significant change of hyponasality, nasal emission, nasal turbulence or passive CTCs. There was significant increase in effective palate length, palate lift and closure ratio with significant decrease of gap size at attempt closure. No significant change was observed in gap size at velar rest position. There was no significant difference observed in speech outcome or velopharyngeal measurements between the different SMCP grades. Secondary pharyngoplasty was necessary in 50% of cases. Discussion/Conclusion: Anatomical muscle dissection velar repair is an effective first-line treatment of SMCP in patients with VCFS. Even in patients who will require secondary pharyngeal surgery to treat residual velopharyngeal incompetence, improvement of velar function following anatomical muscle repair would facilitate a less obstructive pharyngoplasty.
Speech Outcome Following Anatomical Muscle Dissection Velar Repair of the Submucous Cleft Palate (SMCP) in Patients with Velocardiofacial Syndrome (VCFS)
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